ClinicalTrials.gov
ClinicalTrials.gov Menu

System Biology of Spleen Deficiency Syndrome (SBSDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02915393
Recruitment Status : Not yet recruiting
First Posted : September 27, 2016
Last Update Posted : September 27, 2016
Sponsor:
Information provided by (Responsible Party):
Anlong Xu, Beijing University of Chinese Medicine

Brief Summary:
Spleen Deficiency Syndrome(SDS)is a widely researched issue, but due to the limitations of the research methods, the scientific mechanism of SDS is biased and not comprehensive. SDS would be researched in this project deeply and systematically with modern life-scientific methods. Based on the previous work, the participants, with SDS, suffering from Qi deficiency syndrome--chronic superficial gastritis--chronic atrophic gastritis--gastric cancer would be included, and the corresponding research would be conducted at the molecular-cell-gastric tissue level, and at the same time, systematical biological database of SDS would be built by systematical biological methods, such as pioneered SPARS sequencing technology created in our research group, proteomics and metabonomics. Under the above work, the investigators would conduct data mining and molecular network analysis, and then verify the key functions. By analyzing the systematical biological features of syndrome and its relationships with constitution and disease, this study would provide a new basis for objective reality of syndrome, and also offer a crucial premise of revealing biological basis for syndrome correctly, which is of important theoretical and practical significance.

Condition or disease
Gastritis, Atrophic Gastric Cancer

Study Type : Observational
Estimated Enrollment : 90 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: System Biology Research of Spleen Qi Deficiency Associated "Qi Deficiency Constitution-Disease"
Study Start Date : September 2016
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stomach Cancer

Group/Cohort
Healthy Volunteers (BC)
Healthy Volunteers with Balanced Constitution(n=10).
Healthy Volunteers(QC)
Healthy Volunteers with Qi Deficiency Constitution(n=10).
Healthy Volunteers(DC)
Healthy Volunteers with Damp-heat Constitution(n=10).
Superficial Gastritis(SDS)
Superficial Gastritis with Spleen-qi Deficiency Syndrome(n=10).
Superficial Gastritis(DS)
Superficial Gastritis with Damp-heat Syndrome(n=10).
Atrophic Gastritis(SDS)
Atrophic Gastritis with Spleen-qi Deficiency Syndrome(n=10).
Atrophic Gastritis(DS)
Atrophic Gastritis with Damp-heat Syndrome(n=10).
Gastric Cancer(SDS)
Gastric Cancer with Spleen-qi Deficiency Syndrome(n=10).
Gastric Cancer(DS)
Gastric Cancer with Damp-heat Syndrome(n=10).



Primary Outcome Measures :
  1. Examination of the stomach with an endoscope. [ Time Frame: at the beginning of the enrollment ]
    Endoscopic diagnosis standard of chronic gastritis according to Chinese Society of Digestive Endoscopy.

  2. Pathological biopsy of gastric mucosa. [ Time Frame: at the beginning of the enrollment ]
    Pathological diagnosis standard of chronic gastritis according to Chinese Society of Gastroenterology.Pathological diagnosis standard of gastric cancer according to Ministry of Health P.R.China

  3. Detection of helicobacter pylori by Urea Breath Test(UBT) [ Time Frame: at the beginning of the enrollment ]

Secondary Outcome Measures :
  1. Analysis of gastric mucosa/venous blood/urine by system biology techniques [ Time Frame: Three measurements within 1 year ]
  2. Constitutional classification of TCM assessed by the Traditional Chinese Medicine Physical Constitution Scale [ Time Frame: at the beginning of the enrollment ]
  3. TCM syndrome type diagnosed by two professional TCM doctors [ Time Frame: at the beginning of the enrollment ]

Biospecimen Retention:   Samples With DNA
frozen tissue, whole blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
A total of 90 cases will be gathered between August, 2016 and September, 2017. All the cases include: ①10 healthy volunteers in Beijing with balanced constitution, 10 with Qi Deficient Constitution (Spleen-qi Deficiency Syndrome) and 10 with Damp-heat Constitution. ②Patients in Dongfang Hospital diagnosed as chronic superficial gastritis,chronic atrophic gastritis or gastric cancer, 20 for each disease and half of each with Spleen-qi Deficiency Syndrome, half with Spleen Damp-heat Syndrome.
Criteria

Inclusion Criteria:

  • Aged between 18 and 65 years.
  • No apparent abnormality in the routine blood test, urinalysis, routine stool & fecal occult blood test, biochemical test, chest radiograph and electrocardiogram(ECG).
  • The endoscopic diagnoses of chronic superficial gastritis, chronic atrophic gastritis and gastric cancer conform to the corresponding pathological diagnoses
  • TCM diagnoses of Spleen-qi Deficiency Syndrome or Spleen Damp-heat Syndrome.
  • Voluntary participation.
  • Having given written informed consent.

Exclusion Criteria:

  • Gastropathy with special causes, such as acute gastritis, gastrinoma, chronic gastritis resulting from special causes (like granulomatous gastritis, lymphocytic gastritis, eosinophilic gastritis, gastritis after gastric operation) peptic ulcer, other malignant tumors of stomach (like gastric lymphoma, gastri stromal tumor, carcinoid tumor, malignant hemangioma, squamous-cell carcinoma, primary gastric choriocarcinoma and metastatic gastric tumor), benign gastritic tumors that originate from epithelium or submucosa (epithelial tumors like adenomatous polyps and hyperplastic polyps, stromal tumors like benign stromal tumor, neuronal tumor and pseudolymphoma).
  • Combined with other digestive diseases (like gastroesophageal reflux, esophageal varices, acute and chronic hepatitis and cirrhosis arising from various causes, acute/chronic pancreatitis and acute/chronic cholecystitis).
  • Combined with other severe systemic diseases such as respiratory failure, severe cardiovascular and cerebrovascular, immune system, urinary and mental disorders diseases.
  • Pregnancy, or planning pregnancy during the trial or within three month period thereafter.
  • Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02915393


Contacts
Contact: Xiaopu Sang +86 15101021386 sxp@bucm.edu.cn
Contact: Leiming You youleiming@bucm.edu.cn

Sponsors and Collaborators
Beijing University of Chinese Medicine
Investigators
Principal Investigator: Anlong Xu Beijing University of Chinese Medicine

Responsible Party: Anlong Xu, President, Beijing University of Chinese Medicine
ClinicalTrials.gov Identifier: NCT02915393     History of Changes
Other Study ID Numbers: 81430099
First Posted: September 27, 2016    Key Record Dates
Last Update Posted: September 27, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Anlong Xu, Beijing University of Chinese Medicine:
Chronic Gastritis
Qi Deficiency Constitution
Next Generation Sequencing
Proteomics
Metabonomics

Additional relevant MeSH terms:
Stomach Neoplasms
Gastritis
Gastritis, Atrophic
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases
Gastroenteritis